SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-017768
Filing Date
2024-05-03
Accepted
2024-05-03 17:16:21
Documents
20
Period of Report
2024-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47713
2 ex1-1.htm EX-1.1 415668
3 ex4-1.htm EX-4.1 103796
4 ex5-1.htm EX-5.1 15812
5 ex99-1.htm EX-99.1 15465
6 e5-1_001.jpg GRAPHIC 93324
7 ex99-1_001.jpg GRAPHIC 3999
  Complete submission text file 0001493152-24-017768.txt   1023845

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE abeo-20240503.xsd EX-101.SCH 3045
9 XBRL LABEL FILE abeo-20240503_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE abeo-20240503_pre.xml EX-101.PRE 22379
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3679
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 24914408
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)